GLENN JOHN 4

What Happened

• Glenn John, Chief Financial Officer of Iradimed Corporation, had 5,796 restricted stock units (RSUs) convert into common shares on 2026-06-20.
• Of those 5,796 shares, 2,319 were withheld to satisfy tax withholding at $92.20 per share (reported value $213,812). The net shares delivered to the insider were 3,477.
• The full value of the vested 5,796 shares at $92.20 is roughly $534,391.

Key Details

• Transaction date: 2026-06-20; filing date: 2026-06-23 (Form 4 accession 0001253497-26-000005).
• Reported transaction codes: M = exercise/conversion of a derivative (RSU conversion to shares); F = payment of tax liability via share withholding.
• Tax withholding: 2,319 shares withheld at $92.20/share for $213,812 (per filing).
• Net shares received: 3,477 (5,796 vested − 2,319 withheld).
• Shares owned after the transaction: not specified in the filing.
• Footnotes: F1 notes each RSU equals one share on vesting; F2 states the RSUs were granted under the 2014 Equity Incentive Plan and vest in four equal annual installments beginning 6/30/2023.

Context

• This was a routine RSU vesting and share-withholding for taxes (not an open-market sale). Withholding of shares to cover taxes is common and does not necessarily signal a buy or sell intent.
• The filing shows conversion of RSUs (derivative) into shares and the related tax withholding, commonly called a cashless settlement/withholding.